Asia Pacific Metabolomics Market By Product (GC, Bioinformatics, Mass Spectrometry, HPLC, UPLC, NMRS, Surface Based Mass Analysis,), Indication (Oncology, Cardiology, Inborn Errors), Application (Nutrigenomics, Toxicology, Biomarker & Drug Discovery) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia Pacific Metabolomics Market By Product (GC, Bioinformatics, Mass Spectrometry, HPLC, UPLC, NMRS, Surface Based Mass Analysis,), Indication (Oncology, Cardiology, Inborn Errors), Application (Nutrigenomics, Toxicology, Biomarker & Drug Discovery) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 3453 | Pages: 175 | September 2017 | Region: Asia Pacific


The Asia Pacific Metabolomics Market is worth USD0.28 billion in 2016 and estimated to grow at a CAGR of 17.92%, to reach USD.63 billion by 2021. The ASIA PACIFIC Metabolomics market is developing at a very quick speed.

Metabolomics is the rational study of concoction forms comprising metabolites. In particular, metabolomics is the "deliberate investigation of the one of a kind synthetic fingerprints that particular cell forms desert", the study of their little molecules metabolite profiles. The metabolome signify to the accumulation of all metabolites in a natural fleshy tissue, cell, organ or life form, which are the final consequences of cell processes.

The increasing biotech ground-breaking work and pharmaceutical consumption are prompting persistent headways in innovation, spelling development for the worldwide metabolomics market. The developing acceptance of metabolomics in customized medicines is one of the key variables boosting the growth of the market. Then again, there are issues with respect to information handling and information examination, which can represent a test for the market. The high cost of instruments and devices can equally be an issue. Further, the necessity for very much skilled specialists and the absence of the same is limiting the improvement of the metabolomics market.

The Asia Pacific market for Metabolomics is segmented on the basis of product, application, indication and region. Based on product, the market is segmented into GC, Bioinformatics, Mass Spectrometry, HPLC, UPLC, NMRS, and surface based mass analysis. Based on indication, the market is segmented into Oncology, Cardiology, and Inborn Error. Based on application, the market is segmented into Nutrigenomics, Toxicology, and Biomarker & Drug Discovery. Biomarker Discovery segment had largest share in 2016 in the global metabolomics market. Efficiency and reliability has been cited as the reason for the growth of biomarkers. However collaboration between biotechnology and pharmaceutical companies, personalized medical segment is expected to have highest CAGR.

Asia Pacific is geographically segmented into China, India, Japan, South Korea, Taiwan, Australia and South East Asia. China and India are likely to increase the market because of huge population. Also Asia Pacific is largest growing segment.

Agilent Technologies, Inc. (U.S.), Human Metabolome Technologies, Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), LECO Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), Danaher Corporation (U.S.), Biocrates Life Sciences AG (Austria), and Waters Corporation (U.S.) are the leaders in the ASIA PACIFICMetabolomics market.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Metabolomic Instruments                               

                                                5.1.1.1Separation Techniques   

                                                                5.1.1.1.1 Gas Chromatography (GC)

                                                                5.1.1.1.2 Capillary Electrophoresis (CE)

                                                                5.1.1.1.3 High-performance Liquid Chromatography (HPLC)

                                                                5.1.1.1.4 Ultra-performance Liquid Chromatography (UPLC)

                                                5.1.1.2 Detection Tools 

                                                                5.1.1.2.1 Mass Spectrometry

                                                                5.1.1.2.2 Nuclear Magnetic Resonance Spectroscopy

                                                                5.1.1.2.3 Surface-Based Mass Analysis

                                5.1.2 Metabolomics Bioinformatics Tools and Services                   

                                                5.1.2.1 Bioinformatics Tools & Databases              

                                                5.1.2.2 Bioinformatics Services  

                                5.1.3 Y-o-Y Growth Analysis, By Product                               

                                5.1.4 Market Attractiveness Analysis, By Product                             

                                5.1.5 Market Share Analysis, By Product                               

                5.2 Indication                                    

                                5.2.1 Cancer                      

                                5.2.2 Cardiovascular Disorders                   

                                5.2.3 Inborn errors                         

                                5.2.4 Neurological Errors                              

                                5.2.5 Other Indications                 

                                5.2.4 Y-o-Y Growth Analysis, By Indication                           

                                5.2.5 Market Attractiveness Analysis, By Indication                         

                                5.2.6 Market Share Analysis, By Indication                           

                5.3 Application                                 

                                5.3.1 Nutrigenomics                       

                                5.3.2 Toxicology                               

                                5.3.3 Biomarker & Drug Discovery                            

                                5.3.4 Functional Genomics                          

                                5.3.5 Personalized Medicine                      

                                5.3.6 Other Applications

                                5.3.7 Y-o-Y Growth Analysis, By Application                         

                                5.3.8 Market Attractiveness Analysis, By Application                       

                                5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Indication       

                                6.1.4 Market Attractiveness Analysis                      

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Indication       

                                6.1.5 Market Share Analysis                       

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Indication       

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Waters Corporation (U.S.)                                   

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Agilent Technologies, Inc. (U.S.)                                        

                8.3 Human Metabolome Technologies, Inc. (Japan)                                        

                8.4 Thermo Fisher Scientific, Inc. (U.S.)                                 

                8.5 LECO Corporation (U.S.)                                        

                8.6 Bruker Corporation (U.S.)                                    

                8.7 Shimadzu Corporation (Japan)                                           

                8.8 Metabolon Inc. (U.S.)                                            

                8.9 Danaher Corporation (U.S.)                                 

                8.10 Biocrates Life Sciences AG (Austria)                                              

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Metabolomics Market By Product, From 2016-2021 ( USD Million )
  2. Asia-Pacific GC Market By Region, From 2016-2021 ( USD Million )
  3. Asia-Pacific Bioinformatics Market By Region, From 2016-2021 ( USD Million )
  4. Asia-Pacific Mass Spectroscopy Market By Region, From 2016-2021 ( USD Million )
  5. Asia-Pacific HPLC Market By Region, From 2016-2021 ( USD Million )
  6. Asia-Pacific UPLC Market By Region, From 2016-2021 ( USD Million )
  7. Asia-Pacific NMRS Market By Region, From 2016-2021 ( USD Million )
  8. Asia-Pacific Surface Based analysis Market By Region, From 2016-2021 ( USD Million )
  9. Asia-Pacific Metabolomics Market By Indication, From 2016-2021 ( USD Million )
  10. Asia-Pacific Oncology Market By Region, From 2016-2021 ( USD Million )
  11. Asia-Pacific Cardiology Market By Region, From 2016-2021 ( USD Million )
  12. Asia-Pacific Inborn Errors Market By Region, From 2016-2021 ( USD Million )
  13. Asia-Pacific Metabolomics Market By Application, From 2016-2021 ( USD Million )
  14. Asia-Pacific Nutrigenomics Market By Region, From 2016-2021 ( USD Million )
  15. Asia-Pacific Toxicology Market By Region, From 2016-2021 ( USD Million )
  16. Asia-Pacific Biomarker & Drug Discovery Market By Region, From 2016-2021 ( USD Million )
  17. Japan Metabolomics Market By Product, From 2016-2021 ( USD Million )
  18. Japan Metabolomics Market By Indication, From 2016-2021 ( USD Million )
  19. Japan Metabolomics Market By Application, From 2016-2021 ( USD Million )
  20. China Metabolomics Market By Product, From 2016-2021 ( USD Million )
  21. China Metabolomics Market By Indication, From 2016-2021 ( USD Million )
  22. China Metabolomics Market By Application, From 2016-2021 ( USD Million )
  23. India Metabolomics Market By Product, From 2016-2021 ( USD Million )
  24. India Metabolomics Market By Indication, From 2016-2021 ( USD Million )
  25. India Metabolomics Market By Application, From 2016-2021 ( USD Million )
  26. Australia Metabolomics Market By Product, From 2016-2021 ( USD Million )
  27. Australia Metabolomics Market By Indication, From 2016-2021 ( USD Million )
  28. Australia Metabolomics Market By Application, From 2016-2021 ( USD Million )
  29. South Korea Metabolomics Market By Product, From 2016-2021 ( USD Million )
  30. South Korea Metabolomics Market By Indication, From 2016-2021 ( USD Million )
  31. South Korea Metabolomics Market By Application, From 2016-2021 ( USD Million )
Middle East And Africa Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequen...
Latin America Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Tar...
Asia-pacific Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targ...
Europe Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targeted G...
North America Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Tar...
Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targeted Gene Seq...
Middle East And Africa Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Global Indu...
Latin America Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, S...
Asia-Pacific Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, Si...
Europe Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, Size, Sh...
North America Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, S...
Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Global Industry Analysis, Size, Sh...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.